Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany

Eidt D, Greiner W, Mittendorf T, Von der Schulenburg JM (2007)
Value in Health 10(6): A378.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Kurzbeitrag Konferenz | Veröffentlicht | Englisch
Autor
; ; ;
Erscheinungsjahr
Band
10
Zeitschriftennummer
6
Seite
A378
ISSN
PUB-ID

Zitieren

Eidt D, Greiner W, Mittendorf T, Von der Schulenburg JM. Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Value in Health. 2007;10(6):A378.
Eidt, D., Greiner, W., Mittendorf, T., & Von der Schulenburg, J. M. (2007). Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Value in Health, 10(6), A378. doi:10.1016/S1098-3015(10)65334-X
Eidt, D., Greiner, W., Mittendorf, T., and Von der Schulenburg, J. M. (2007). Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Value in Health 10, A378.
Eidt, D., et al., 2007. Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Value in Health, 10(6), p A378.
D. Eidt, et al., “Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany”, Value in Health, vol. 10, 2007, pp. A378.
Eidt, D., Greiner, W., Mittendorf, T., Von der Schulenburg, J.M.: Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Value in Health. 10, A378 (2007).
Eidt, D., Greiner, Wolfgang, Mittendorf, T., and Von der Schulenburg, J. M. “Validity of a child-friendly EQ-5D as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany”. Value in Health 10.6 (2007): A378.